Penumbra, Inc Revenue
Penumbra, Inc (PEN) reported Revenue of $390.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-07-30
- Penumbra, Inc revenues for the quarter ending 2026-06-30 was $390.05M, a 14.90% increase year-over-year.
- Penumbra, Inc revenues for the quarter ending 2026-03-31 was $374.76M, a 15.62% increase year-over-year.
- Penumbra, Inc revenues for the quarter ending 2025-12-31 was $385.38M, a 22.14% increase year-over-year.
- Penumbra, Inc revenues for the quarter ending 2025-09-30 was $354.69M, a 17.82% increase year-over-year.
- Penumbra, Inc revenues for fiscal 2025 was $1.40B, a 17.50% increase from fiscal 2024.
- Penumbra, Inc revenues for fiscal 2024 was $1.19B, a 12.86% increase from fiscal 2023.
- Penumbra, Inc revenues for fiscal 2023 was $1.06B, a 24.95% increase from fiscal 2022.
- Penumbra, Inc revenues for fiscal 2022 was $847.13M, a 13.32% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $390.05M 10-Q · filed 2026-07-30 | $764.80M 10-Q · filed 2026-07-30 | $1.15B derived: sum of 3 quarters · filed 2026-07-30 | $1.50B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $374.76M 10-Q · filed 2026-05-06 | $760.14M derived: sum of 2 quarters · filed 2026-05-06 | $1.11B derived: sum of 3 quarters · filed 2026-05-06 | $1.45B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $385.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $740.07M derived: sum of 2 quarters · filed 2026-02-25 | $1.08B derived: sum of 3 quarters · filed 2026-07-30 | $1.40B 10-K · filed 2026-02-25 |
| 2025-09-30 | $354.69M 10-Q · filed 2025-11-05 | $694.14M derived: sum of 2 quarters · filed 2026-07-30 | $1.02B 10-Q · filed 2025-11-05 | $1.33B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $339.45M 10-Q · filed 2026-07-30 | $663.60M 10-Q · filed 2026-07-30 | $979.11M derived: sum of 3 quarters · filed 2026-07-30 | $1.28B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $324.14M 10-Q · filed 2026-05-06 | $639.66M derived: sum of 2 quarters · filed 2026-05-06 | $940.70M derived: sum of 3 quarters · filed 2026-05-06 | $1.24B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $315.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $616.56M derived: sum of 2 quarters · filed 2026-02-25 | $915.96M derived: sum of 3 quarters · filed 2026-02-25 | $1.19B 10-K · filed 2026-02-25 |
| 2024-09-30 | $301.04M 10-Q · filed 2025-11-05 | $600.44M derived: sum of 2 quarters · filed 2025-11-05 | $879.10M 10-Q · filed 2025-11-05 | $1.16B derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $299.40M 10-Q · filed 2025-07-29 | $578.06M 10-Q · filed 2025-07-29 | $862.74M derived: sum of 3 quarters · filed 2025-07-29 | $1.13B derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $278.65M 10-Q · filed 2025-04-23 | $563.33M derived: sum of 2 quarters · filed 2025-04-23 | $834.28M derived: sum of 3 quarters · filed 2025-04-23 | $1.10B derived: sum of 4 quarters · filed 2025-04-23 |
| 2023-12-31 | $284.68M 10-K · filed 2024-02-22 | $555.63M derived: sum of 2 quarters · filed 2024-10-30 | $817.12M derived: sum of 3 quarters · filed 2024-10-30 | $1.06B 10-K · filed 2026-02-25 |
| 2023-09-30 | $270.95M 10-Q · filed 2024-10-30 | $532.45M derived: sum of 2 quarters · filed 2024-10-30 | $773.84M 10-Q · filed 2024-10-30 | $995.06M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $261.50M 10-Q · filed 2024-07-30 | $502.90M 10-Q · filed 2024-07-30 | $724.11M derived: sum of 3 quarters · filed 2024-07-30 | $937.79M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $241.40M 10-Q · filed 2024-05-07 | $462.61M derived: sum of 2 quarters · filed 2024-05-07 | $676.29M derived: sum of 3 quarters · filed 2024-05-07 | $884.64M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $221.22M 10-K · filed 2024-02-22 | $434.89M derived: sum of 2 quarters · filed 2024-02-22 | $643.24M derived: sum of 3 quarters · filed 2024-02-22 | $847.13M 10-K · filed 2025-02-18 |
| 2022-09-30 | $213.68M 10-K · filed 2024-02-22 | $422.02M derived: sum of 2 quarters · filed 2024-02-22 | $625.92M 10-Q · filed 2023-11-02 | $829.93M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $208.34M 10-K · filed 2024-02-22 | $412.24M 10-Q · filed 2023-08-01 | $616.25M derived: sum of 3 quarters · filed 2024-02-22 | $806.37M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $203.90M 10-K · filed 2024-02-22 | $407.91M derived: sum of 2 quarters · filed 2024-02-22 | $598.02M derived: sum of 3 quarters · filed 2024-02-22 | $782.28M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $204.01M 10-K · filed 2023-02-23 | $394.13M derived: sum of 2 quarters · filed 2023-02-23 | $578.39M derived: sum of 3 quarters · filed 2023-02-23 | $747.59M 10-K · filed 2024-02-22 |
| 2021-09-30 | $190.12M 10-K · filed 2023-02-23 | $374.38M derived: sum of 2 quarters · filed 2023-02-23 | $543.58M 10-Q · filed 2022-11-03 | $710.48M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $184.26M 10-K · filed 2023-02-23 | $353.46M 10-Q · filed 2022-08-05 | $520.36M derived: sum of 3 quarters · filed 2023-02-23 | $671.44M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $169.20M 10-K · filed 2023-02-23 | $336.10M derived: sum of 2 quarters · filed 2023-02-23 | $487.18M derived: sum of 3 quarters · filed 2023-02-23 | $592.29M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $166.90M 10-K · filed 2022-02-22 | $317.97M derived: sum of 2 quarters · filed 2022-02-22 | $423.08M derived: sum of 3 quarters · filed 2022-02-22 | $560.41M 10-K · filed 2023-02-23 |
| 2020-09-30 | $151.08M 10-K · filed 2022-02-22 | $256.19M derived: sum of 2 quarters · filed 2022-02-22 | $393.51M 10-Q · filed 2021-11-03 | $538.78M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $105.11M 10-K · filed 2022-02-22 | $242.44M 10-Q · filed 2021-08-09 | $387.70M derived: sum of 3 quarters · filed 2022-02-22 | $527.20M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $137.33M 10-K · filed 2022-02-22 | $282.59M derived: sum of 2 quarters · filed 2022-02-22 | $422.09M derived: sum of 3 quarters · filed 2022-02-22 | $556.29M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $145.26M 10-K · filed 2021-02-23 | $284.76M derived: sum of 2 quarters · filed 2021-02-23 | $418.97M derived: sum of 3 quarters · filed 2021-02-23 | $547.40M 10-K · filed 2022-02-22 |
| 2019-09-30 | $139.50M 10-K · filed 2021-02-23 | $273.70M derived: sum of 2 quarters · filed 2021-02-23 | $402.14M 10-Q · filed 2020-11-02 | $522.93M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $134.20M 10-K · filed 2021-02-23 | $262.64M 10-Q · filed 2020-08-03 | $383.43M derived: sum of 3 quarters · filed 2021-02-23 | $495.24M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $128.44M 10-K · filed 2021-02-23 | $249.23M derived: sum of 2 quarters · filed 2021-02-23 | $361.04M derived: sum of 3 quarters · filed 2021-02-23 | $470.68M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $120.79M 10-K · filed 2020-02-26 | $232.60M derived: sum of 2 quarters · filed 2020-02-26 | $342.24M derived: sum of 3 quarters · filed 2020-02-26 | $444.94M 10-K · filed 2021-02-23 |
| 2018-09-30 | $111.81M 10-K · filed 2020-02-26 | $221.44M derived: sum of 2 quarters · filed 2020-02-26 | $324.14M 10-Q · filed 2019-11-07 | $420.20M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $109.64M 10-K · filed 2020-02-26 | $212.34M 10-Q · filed 2019-08-06 | $308.39M derived: sum of 3 quarters · filed 2020-02-26 | $392.30M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $102.70M 10-K · filed 2020-02-26 | $198.75M derived: sum of 2 quarters · filed 2020-02-26 | $282.66M derived: sum of 3 quarters · filed 2020-02-26 | $363.25M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $96.05M 10-K · filed 2019-02-26 | $179.96M derived: sum of 2 quarters · filed 2019-02-26 | $260.55M derived: sum of 3 quarters · filed 2019-02-26 | $333.76M 10-K · filed 2020-02-26 |
| 2017-09-30 | $83.91M 10-K · filed 2019-02-26 | $164.50M derived: sum of 2 quarters · filed 2019-02-26 | $237.71M derived: sum of 3 quarters · filed 2019-02-26 | |
| 2017-06-30 | $80.59M 10-K · filed 2019-02-26 | $153.80M derived: sum of 2 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $73.21M 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $263.32M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |